Clinicopathological Profile of Endometrioid Endometrial Carcinoma at Saiful Anwar General Hospital from 2022 until 2024

Authors

  • Amelinda Natania Nurasih Departemen Patologi Anatomi, Fakultas Kedokteran Universitas Brawijaya, Malang, Indonesia
  • Ihda Dian Kusuma Laboratorium Patologi Anatomi, RSUD Saiful Anwar , Malang, Indonesia
  • Arif Satria Hardika Laboratorium Patologi Anatomi, RSUD Saiful Anwar , Malang, Indonesia

DOI:

https://doi.org/10.11594/jk-risk.05.3.2

Keywords:

Endometrial carcinoma, clinicopathological profile, histological grade, menopause, obesity

Abstract

Background: Endometrial carcinoma holds the second highest incidence among gynecologic malignancies after cervical cancer, with increasing incidence and mortality globally. While it predominantly affects postmenopausal women, its incidence is steadily rising among premenopausal women. As the most prevalent subtype, endometrioid endometrial carcinoma (EEC) is closely linked to extended periods of unopposed estrogen stimulation. Obesity, type 2 diabetes, and nulliparity are also recognized as contributing risk factors.

Aim: To describe the clinicopathological profile of EEC at Dr. Saiful Anwar General Hospital.

Methods: This study employed a descriptive retrospective design based on secondary data obtained from medical records and histopathology reports. Inclusion criteria were patients diagnosed with EEC through hysterectomy specimens.

Results: EEC cases increased over the past three years, with a 48% surge in 2024. Most patients were aged 51–60 years (mean age: 56.5) and showed deep myometrial invasion (≥½ thickness, 71.43%). The most common histological findings were FIGO grade 1 (45.23%) and stage IB (33.33%). Reproductive risk factors included postmenopausal status (63.3%), premenopausal status (36.67%), and nulliparity (23.3%). Among the patients, 18.33% had a history of diabetes mellitus, and 48.33% were obese (mean BMI: 27.83 kg/m²).

Conclusion: There is a consistent upward trend in EEC incidence, with most patients diagnosed at an early stage and grade. An increasing proportion of cases is observed among obese and premenopausal women, with the youngest patient aged 29. Early detection and risk-based preventive strategies are essential to reduce EEC incidence and mortality.

Downloads

Download data is not yet available.

References

PNPK HOGI 2018 Pedoman Nasional Ginekologi.

World Health Organization. Global Cancer Observatory GLOBOCAN 2022 [Internet]. [cited 2025 Apr 19];Available from: https://gco.iarc.who.int/today/en

Zhu B, Gu H, Mao Z, Beeraka NM, Zhao X, Anand MP, et al. Global burden of gynaecological cancers in 2022 and projections to 2050. J Glob Health 2024;14. https://doi.org/10.7189/JOGH.14.04155

Baker-Rand H, Kitson SJ. Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment. Cancers (Basel)2024;16. https://doi.org/10.3390/cancers16051028

Gu B, Shang X. Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990-2019. Gynecologic Oncology. 2021;161(2):573–80. https://doi.org/10.1016/j.ygyno.2021.01.036

Kurman RJ, Ellenson LH. Blaustein’s Pathology of the Female Genital Tract. Seventh edition. Switzerland: Springer; 2019.

Bassette E, Ducie JA. Endometrial Cancer in Reproductive-Aged Females: Etiology and Pathogenesis. Biomedicines2024;12. https://doi.org/10.3390/biomedicines12040886

WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th edition. France: International Agency for Research on Cancer; 2020.

Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. International Journal of Gynecology and Obstetrics 2023;162:383–94. https://doi.org/10.1002/ijgo.14923

Haam JH, Kim BT, Kim EM, Kwon H, Kang JH, Park JH, et al. Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity. J Obes Metab Syndr2023;32:121–9. https://doi.org/10.7570/jomes23031

Sofyan N, Sudiana IK, Askandar B. Profile of Endometrial Cancer Patients in the Third Referral Hospital in Surabaya based on Known Risk Factors. Biomolecular and Health Science Journal 2020;3:66. https://doi.org/10.20473/bhsj.v3i2.22141

Erfiandi F, Kurniadi A, Balqis SAA, Salima S, Mantilidewi KI, Kurniadi A, et al. Penderita Kanker Endometrium di RSUP Dr. Hasan Sadikin Bandung Periode Tahun 2020-2022. Indonesian Journal of Obstetrics & Gynecology Science 2023;6:3. https://doi.org/10.24198/obgynia.v6i3.578

Nief CA, Long SE, McCleary TL, Kidd E. Diabetes mellitus complications associated with recurrence of stage I endometrioid endometrial cancer: A single-center retrospective study. Gynecologic Oncology 2024;190:298–306. https://doi.org/10.1016/j.ygyno.2024.09.007

Kumar Vinay, Abbas AK, Aster JC, Perkins JA. Robbins and Cotran Pathologic Basis of Disease. Tenth edition. Philadelphia: Elsevier; 2021.

Christina S, Kartika Setyaningsih C, Pelita P, Hermawan S. Hubungan Invasi Miometrium dengan Invasi Limfovaskular dan Grade Histologik pada Karsinoma Endometrium. Jurnal Kedokteran Yarsi. 2019; 27 (3) : 132-143. https://doi.org/10.33476/jky.v27i3.1204

Chen JR, Chang TC, Fu HC, Lau HY, Chen IH, Ke YM, et al. Outcomes of Patients with Surgically and Pathologically Staged IIIA-IVB Pure Endometrioid-type Endometrial Cancer. Medicine (United States) 2016;95. https://doi.org/10.1097/MD.0000000000003330

Gaillard S, Hopkins Kimmel Cancer Center Robert Giuntoli JI, Glaser S, Howitt BE, Landrum L, Lea J, et al. NCCN Clinical Practice Guidelines In Oncology (Uterine Neoplasm) Version 3.2025 [Internet]. 2025. Available from: https://www.nccn.org/home/member-

Downloads

Published

2026-06-26

How to Cite

Natania Nurasih, A., Kusuma, I., & Hardika, H. (2026). Clinicopathological Profile of Endometrioid Endometrial Carcinoma at Saiful Anwar General Hospital from 2022 until 2024. Jurnal Klinik Dan Riset Kesehatan, 5(3), 182-190. https://doi.org/10.11594/jk-risk.05.3.2